Covid-19 Impact on Global Mesalazine Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 29-Apr-2020
No. of pages: 110
Inquire Before Buying

Mesalazine, also known as mesalamine or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

The industry's leading manufacturers are Syntese A/S, Divis Laboratories and Cambrex Corporation, which accounted for 24.07%, 12.91% and 6.61% of revenues in 2019, respectively. In terms of regions, the revenue share in Europe is the highest, reaching 46.73% in 2019.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Mesalazine 3900 market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Mesalazine 3900 industry.

Based on our recent survey, we have several different scenarios about the Mesalazine 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 134.6 million in 2019. The market size of Mesalazine 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mesalazine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mesalazine market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Mesalazine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Sales and Pricing Analyses

Readers are provided with deeper sales analysis and pricing analysis for the global Mesalazine market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Mesalazine market, covering important regions, viz, United States, Europe, China and India. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Mesalazine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mesalazine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mesalazine market.

The following manufacturers are covered in this report:

- Syntese A/S

- Divis Laboratories

- Cambrex Corporation

- Ipca Laboratories

- PharmaZell

- Lasa Loboratory

- Erregierre SpA

- Corden Pharma Bergamo

- CTX Lifescience

- Ishita Active Pharma Ingredients

- YC Biotech (Jiangsu)

- Xinxiang Tianfeng Fine Chemical

Mesalazine Breakdown Data by Type

- Purity = 97 %

- Purity = 98 %

- Purity = 99 %

- According to the type, purity = 98% is the highest, reaching 48.44% in 2019.

Mesalazine Breakdown Data by Application

- Mesalazine Tablets

- Mesalazine Capsules

- Others

Covid-19 Impact on Global Mesalazine Market Size, Status and Forecast 2020-2026

Table of Contents
1 Study Coverage
1.1 Mesalazine Product Introduction
1.2 Market Segments
1.3 Key Mesalazine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Mesalazine Market Size Growth Rate by Type
1.4.2 Purity = 97 %
1.4.3 Purity = 98 %
1.4.4 Purity = 99 %
1.5 Market by Application
1.5.1 Global Mesalazine Market Size Growth Rate by Application
1.5.2 Mesalazine Tablets
1.5.3 Mesalazine Capsules
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Mesalazine Industry Impact
1.6.1 How the Covid-19 is Affecting the Mesalazine Industry
1.6.1.1 Mesalazine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Mesalazine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Mesalazine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Mesalazine Market Size Estimates and Forecasts
2.1.1 Global Mesalazine Revenue 2015-2026
2.1.2 Global Mesalazine Sales 2015-2026
2.2 Mesalazine Market Size by Region: 2020 Versus 2026
2.2.1 Global Mesalazine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Mesalazine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Mesalazine Competitor Landscape by Players
3.1 Mesalazine Sales by Manufacturers
3.1.1 Mesalazine Sales by Manufacturers (2015-2020)
3.1.2 Mesalazine Sales Market Share by Manufacturers (2015-2020)
3.2 Mesalazine Revenue by Manufacturers
3.2.1 Mesalazine Revenue by Manufacturers (2015-2020)
3.2.2 Mesalazine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Mesalazine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Mesalazine Revenue in 2019
3.2.5 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Mesalazine Price by Manufacturers
3.4 Mesalazine Manufacturing Base Distribution, Product Types
3.4.1 Mesalazine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mesalazine Product Type
3.4.3 Date of International Manufacturers Enter into Mesalazine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Mesalazine Market Size by Type (2015-2020)
4.1.1 Global Mesalazine Sales by Type (2015-2020)
4.1.2 Global Mesalazine Revenue by Type (2015-2020)
4.1.3 Mesalazine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Mesalazine Market Size Forecast by Type (2021-2026)
4.2.1 Global Mesalazine Sales Forecast by Type (2021-2026)
4.2.2 Global Mesalazine Revenue Forecast by Type (2021-2026)
4.2.3 Mesalazine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Mesalazine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Mesalazine Market Size by Application (2015-2020)
5.1.1 Global Mesalazine Sales by Application (2015-2020)
5.1.2 Global Mesalazine Revenue by Application (2015-2020)
5.1.3 Mesalazine Price by Application (2015-2020)
5.2 Mesalazine Market Size Forecast by Application (2021-2026)
5.2.1 Global Mesalazine Sales Forecast by Application (2021-2026)
5.2.2 Global Mesalazine Revenue Forecast by Application (2021-2026)
5.2.3 Global Mesalazine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Mesalazine by Country
6.1.1 North America Mesalazine Sales by Country
6.1.2 North America Mesalazine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Mesalazine Market Facts & Figures by Type
6.3 North America Mesalazine Market Facts & Figures by Application
7 Europe
7.1 Europe Mesalazine by Country
7.1.1 Europe Mesalazine Sales by Country
7.1.2 Europe Mesalazine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Mesalazine Market Facts & Figures by Type
7.3 Europe Mesalazine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Mesalazine by Region
8.1.1 Asia Pacific Mesalazine Sales by Region
8.1.2 Asia Pacific Mesalazine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Mesalazine Market Facts & Figures by Type
8.3 Asia Pacific Mesalazine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Mesalazine by Country
9.1.1 Latin America Mesalazine Sales by Country
9.1.2 Latin America Mesalazine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Mesalazine Market Facts & Figures by Type
9.3 Central & South America Mesalazine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Mesalazine by Country
10.1.1 Middle East and Africa Mesalazine Sales by Country
10.1.2 Middle East and Africa Mesalazine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Mesalazine Market Facts & Figures by Type
10.3 Middle East and Africa Mesalazine Market Facts & Figures by Application
11 Company Profiles
11.1 Syntese A/S
11.1.1 Syntese A/S Corporation Information
11.1.2 Syntese A/S Description, Business Overview and Total Revenue
11.1.3 Syntese A/S Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Syntese A/S Mesalazine Products Offered
11.1.5 Syntese A/S Recent Development
11.2 Divis Laboratories
11.2.1 Divis Laboratories Corporation Information
11.2.2 Divis Laboratories Description, Business Overview and Total Revenue
11.2.3 Divis Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Divis Laboratories Mesalazine Products Offered
11.2.5 Divis Laboratories Recent Development
11.3 Cambrex Corporation
11.3.1 Cambrex Corporation Corporation Information
11.3.2 Cambrex Corporation Description, Business Overview and Total Revenue
11.3.3 Cambrex Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cambrex Corporation Mesalazine Products Offered
11.3.5 Cambrex Corporation Recent Development
11.4 Ipca Laboratories
11.4.1 Ipca Laboratories Corporation Information
11.4.2 Ipca Laboratories Description, Business Overview and Total Revenue
11.4.3 Ipca Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ipca Laboratories Mesalazine Products Offered
11.4.5 Ipca Laboratories Recent Development
11.5 PharmaZell
11.5.1 PharmaZell Corporation Information
11.5.2 PharmaZell Description, Business Overview and Total Revenue
11.5.3 PharmaZell Sales, Revenue and Gross Margin (2015-2020)
11.5.4 PharmaZell Mesalazine Products Offered
11.5.5 PharmaZell Recent Development
11.6 Lasa Loboratory
11.6.1 Lasa Loboratory Corporation Information
11.6.2 Lasa Loboratory Description, Business Overview and Total Revenue
11.6.3 Lasa Loboratory Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Lasa Loboratory Mesalazine Products Offered
11.6.5 Lasa Loboratory Recent Development
11.7 Erregierre SpA
11.7.1 Erregierre SpA Corporation Information
11.7.2 Erregierre SpA Description, Business Overview and Total Revenue
11.7.3 Erregierre SpA Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Erregierre SpA Mesalazine Products Offered
11.7.5 Erregierre SpA Recent Development
11.8 Corden Pharma Bergamo
11.8.1 Corden Pharma Bergamo Corporation Information
11.8.2 Corden Pharma Bergamo Description, Business Overview and Total Revenue
11.8.3 Corden Pharma Bergamo Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Corden Pharma Bergamo Mesalazine Products Offered
11.8.5 Corden Pharma Bergamo Recent Development
11.9 CTX Lifescience
11.9.1 CTX Lifescience Corporation Information
11.9.2 CTX Lifescience Description, Business Overview and Total Revenue
11.9.3 CTX Lifescience Sales, Revenue and Gross Margin (2015-2020)
11.9.4 CTX Lifescience Mesalazine Products Offered
11.9.5 CTX Lifescience Recent Development
11.10 Ishita Active Pharma Ingredients
11.10.1 Ishita Active Pharma Ingredients Corporation Information
11.10.2 Ishita Active Pharma Ingredients Description, Business Overview and Total Revenue
11.10.3 Ishita Active Pharma Ingredients Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Ishita Active Pharma Ingredients Mesalazine Products Offered
11.10.5 Ishita Active Pharma Ingredients Recent Development
11.1 Syntese A/S
11.1.1 Syntese A/S Corporation Information
11.1.2 Syntese A/S Description, Business Overview and Total Revenue
11.1.3 Syntese A/S Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Syntese A/S Mesalazine Products Offered
11.1.5 Syntese A/S Recent Development
11.12 Xinxiang Tianfeng Fine Chemical
11.12.1 Xinxiang Tianfeng Fine Chemical Corporation Information
11.12.2 Xinxiang Tianfeng Fine Chemical Description, Business Overview and Total Revenue
11.12.3 Xinxiang Tianfeng Fine Chemical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Xinxiang Tianfeng Fine Chemical Products Offered
11.12.5 Xinxiang Tianfeng Fine Chemical Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Mesalazine Market Estimates and Projections by Region
12.1.1 Global Mesalazine Sales Forecast by Regions 2021-2026
12.1.2 Global Mesalazine Revenue Forecast by Regions 2021-2026
12.2 North America Mesalazine Market Size Forecast (2021-2026)
12.2.1 North America: Mesalazine Sales Forecast (2021-2026)
12.2.2 North America: Mesalazine Revenue Forecast (2021-2026)
12.2.3 North America: Mesalazine Market Size Forecast by Country (2021-2026)
12.3 Europe Mesalazine Market Size Forecast (2021-2026)
12.3.1 Europe: Mesalazine Sales Forecast (2021-2026)
12.3.2 Europe: Mesalazine Revenue Forecast (2021-2026)
12.3.3 Europe: Mesalazine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Mesalazine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Mesalazine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Mesalazine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Mesalazine Market Size Forecast by Region (2021-2026)
12.5 Latin America Mesalazine Market Size Forecast (2021-2026)
12.5.1 Latin America: Mesalazine Sales Forecast (2021-2026)
12.5.2 Latin America: Mesalazine Revenue Forecast (2021-2026)
12.5.3 Latin America: Mesalazine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Mesalazine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Mesalazine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Mesalazine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Mesalazine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Mesalazine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mesalazine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Mesalazine Market Segments
Table 2. Ranking of Global Top Mesalazine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Mesalazine Market Size Growth Rate by Type 2020-2026 (Ton) & (US$ Million)
Table 4. Major Manufacturers of Purity = 97 %
Table 5. Major Manufacturers of Purity = 98 %
Table 6. Major Manufacturers of Purity = 99 %
Table 7. COVID-19 Impact Global Market: (Four Mesalazine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Mesalazine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Mesalazine Players to Combat Covid-19 Impact
Table 12. Global Mesalazine Market Size Growth Rate by Application 2020-2026 (Ton)
Table 13. Global Mesalazine Market Size by Region (Ton) & (US$ Million): 2020 VS 2026
Table 14. Global Mesalazine Sales by Regions 2015-2020 (Ton)
Table 15. Global Mesalazine Sales Market Share by Regions (2015-2020)
Table 16. Global Mesalazine Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Mesalazine Sales by Manufacturers (2015-2020) (Ton)
Table 18. Global Mesalazine Sales Share by Manufacturers (2015-2020)
Table 19. Global Mesalazine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Mesalazine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalazine as of 2019)
Table 21. Mesalazine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Mesalazine Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Mesalazine Price (2015-2020) (US$/Kg)
Table 24. Mesalazine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Mesalazine Product Type
Table 26. Date of International Manufacturers Enter into Mesalazine Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Mesalazine Sales by Type (2015-2020) (Ton)
Table 29. Global Mesalazine Sales Share by Type (2015-2020)
Table 30. Global Mesalazine Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Mesalazine Revenue Share by Type (2015-2020)
Table 32. Mesalazine Average Selling Price (ASP) by Type 2015-2020 (US$/Kg)
Table 33. Global Mesalazine Sales by Application (2015-2020) (Ton)
Table 34. Global Mesalazine Sales Share by Application (2015-2020)
Table 35. North America Mesalazine Sales by Country (2015-2020) (Ton)
Table 36. North America Mesalazine Sales Market Share by Country (2015-2020)
Table 37. North America Mesalazine Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Mesalazine Revenue Market Share by Country (2015-2020)
Table 39. North America Mesalazine Sales by Type (2015-2020) (Ton)
Table 40. North America Mesalazine Sales Market Share by Type (2015-2020)
Table 41. North America Mesalazine Sales by Application (2015-2020) (Ton)
Table 42. North America Mesalazine Sales Market Share by Application (2015-2020)
Table 43. Europe Mesalazine Sales by Country (2015-2020) (Ton)
Table 44. Europe Mesalazine Sales Market Share by Country (2015-2020)
Table 45. Europe Mesalazine Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Mesalazine Revenue Market Share by Country (2015-2020)
Table 47. Europe Mesalazine Sales by Type (2015-2020) (Ton)
Table 48. Europe Mesalazine Sales Market Share by Type (2015-2020)
Table 49. Europe Mesalazine Sales by Application (2015-2020) (Ton)
Table 50. Europe Mesalazine Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Mesalazine Sales by Region (2015-2020) (Ton)
Table 52. Asia Pacific Mesalazine Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Mesalazine Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Mesalazine Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Mesalazine Sales by Type (2015-2020) (Ton)
Table 56. Asia Pacific Mesalazine Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Mesalazine Sales by Application (2015-2020) (Ton)
Table 58. Asia Pacific Mesalazine Sales Market Share by Application (2015-2020)
Table 59. Latin America Mesalazine Sales by Country (2015-2020) (Ton)
Table 60. Latin America Mesalazine Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Mesalazine Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Mesalazine Revenue Market Share by Country (2015-2020)
Table 63. Latin America Mesalazine Sales by Type (2015-2020) (Ton)
Table 64. Latin America Mesalazine Sales Market Share by Type (2015-2020)
Table 65. Latin America Mesalazine Sales by Application (2015-2020) (Ton)
Table 66. Latin America Mesalazine Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Mesalazine Sales by Country (2015-2020) (Ton)
Table 68. Middle East and Africa Mesalazine Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Mesalazine Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Mesalazine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Mesalazine Sales by Type (2015-2020) (Ton)
Table 72. Middle East and Africa Mesalazine Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Mesalazine Sales by Application (2015-2020) (Ton)
Table 74. Middle East and Africa Mesalazine Sales Market Share by Application (2015-2020)
Table 75. Syntese A/S Corporation Information
Table 76. Syntese A/S Description and Major Businesses
Table 77. Syntese A/S Mesalazine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 78. Syntese A/S Product
Table 79. Syntese A/S Recent Development
Table 80. Divis Laboratories Corporation Information
Table 81. Divis Laboratories Description and Major Businesses
Table 82. Divis Laboratories Mesalazine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 83. Divis Laboratories Product
Table 84. Divis Laboratories Recent Development
Table 85. Cambrex Corporation Corporation Information
Table 86. Cambrex Corporation Description and Major Businesses
Table 87. Cambrex Corporation Mesalazine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 88. Cambrex Corporation Product
Table 89. Cambrex Corporation Recent Development
Table 90. Ipca Laboratories Corporation Information
Table 91. Ipca Laboratories Description and Major Businesses
Table 92. Ipca Laboratories Mesalazine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 93. Ipca Laboratories Product
Table 94. Ipca Laboratories Recent Development
Table 95. PharmaZell Corporation Information
Table 96. PharmaZell Description and Major Businesses
Table 97. PharmaZell Mesalazine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 98. PharmaZell Product
Table 99. PharmaZell Recent Development
Table 100. Lasa Loboratory Corporation Information
Table 101. Lasa Loboratory Description and Major Businesses
Table 102. Lasa Loboratory Mesalazine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 103. Lasa Loboratory Product
Table 104. Lasa Loboratory Recent Development
Table 105. Erregierre SpA Corporation Information
Table 106. Erregierre SpA Description and Major Businesses
Table 107. Erregierre SpA Mesalazine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 108. Erregierre SpA Product
Table 109. Erregierre SpA Recent Development
Table 110. Corden Pharma Bergamo Corporation Information
Table 111. Corden Pharma Bergamo Description and Major Businesses
Table 112. Corden Pharma Bergamo Mesalazine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 113. Corden Pharma Bergamo Product
Table 114. Corden Pharma Bergamo Recent Development
Table 115. CTX Lifescience Corporation Information
Table 116. CTX Lifescience Description and Major Businesses
Table 117. CTX Lifescience Mesalazine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 118. CTX Lifescience Product
Table 119. CTX Lifescience Recent Development
Table 120. Ishita Active Pharma Ingredients Corporation Information
Table 121. Ishita Active Pharma Ingredients Description and Major Businesses
Table 122. Ishita Active Pharma Ingredients Mesalazine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 123. Ishita Active Pharma Ingredients Product
Table 124. Ishita Active Pharma Ingredients Recent Development
Table 125. YC Biotech (Jiangsu) Corporation Information
Table 126. YC Biotech (Jiangsu) Description and Major Businesses
Table 127. YC Biotech (Jiangsu) Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 128. YC Biotech (Jiangsu) Product
Table 129. YC Biotech (Jiangsu) Recent Development
Table 130. Xinxiang Tianfeng Fine Chemical Corporation Information
Table 131. Xinxiang Tianfeng Fine Chemical Description and Major Businesses
Table 132. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 133. Xinxiang Tianfeng Fine Chemical Product
Table 134. Xinxiang Tianfeng Fine Chemical Recent Development
Table 135. Global Mesalazine Sales Forecast by Regions (2021-2026) (Ton)
Table 136. Global Mesalazine Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Mesalazine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Mesalazine Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Mesalazine Sales Forecast by Country (2021-2026) (Ton)
Table 140. North America: Mesalazine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Mesalazine Sales Forecast by Country (2021-2026) (Ton)
Table 142. Europe: Mesalazine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Mesalazine Sales Forecast by Region (2021-2026) (Ton)
Table 144. Asia Pacific: Mesalazine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Mesalazine Sales Forecast by Country (2021-2026) (Ton)
Table 146. Latin America: Mesalazine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Mesalazine Sales Forecast by Country (2021-2026) (Ton)
Table 148. Middle East and Africa: Mesalazine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Mesalazine Players
Table 153. Mesalazine Customers List
Table 154. Mesalazine Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Mesalazine Product Picture
Figure 2. Global Mesalazine Sales Market Share by Type in 2020 & 2026
Figure 3. Purity = 97 % Product Picture
Figure 4. Purity = 98 % Product Picture
Figure 5. Purity = 99 % Product Picture
Figure 6. Global Mesalazine Sales Market Share by Application in 2020 & 2026
Figure 7. Mesalazine Tablets
Figure 8. Mesalazine Capsules
Figure 9. Others
Figure 10. Mesalazine Report Years Considered
Figure 11. Global Mesalazine Market Size 2015-2026 (US$ Million)
Figure 12. Global Mesalazine Sales 2015-2026 (Ton)
Figure 13. Global Mesalazine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Mesalazine Sales Market Share by Region (2015-2020)
Figure 15. Global Mesalazine Sales Market Share by Region in 2019
Figure 16. Global Mesalazine Revenue Market Share by Region (2015-2020)
Figure 17. Global Mesalazine Revenue Market Share by Region in 2019
Figure 18. Global Mesalazine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Mesalazine Revenue in 2019
Figure 20. Mesalazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Mesalazine Sales Market Share by Type (2015-2020)
Figure 22. Global Mesalazine Sales Market Share by Type in 2019
Figure 23. Global Mesalazine Revenue Market Share by Type (2015-2020)
Figure 24. Global Mesalazine Revenue Market Share by Type in 2019
Figure 25. Global Mesalazine Market Share by Price Range (2015-2020)
Figure 26. Global Mesalazine Sales Market Share by Application (2015-2020)
Figure 27. Global Mesalazine Sales Market Share by Application in 2019
Figure 28. Global Mesalazine Revenue Market Share by Application (2015-2020)
Figure 29. Global Mesalazine Revenue Market Share by Application in 2019
Figure 30. North America Mesalazine Sales Growth Rate 2015-2020 (Ton)
Figure 31. North America Mesalazine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Mesalazine Sales Market Share by Country in 2019
Figure 33. North America Mesalazine Revenue Market Share by Country in 2019
Figure 34. U.S. Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 35. U.S. Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 37. Canada Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Mesalazine Market Share by Type in 2019
Figure 39. North America Mesalazine Market Share by Application in 2019
Figure 40. Europe Mesalazine Sales Growth Rate 2015-2020 (Ton)
Figure 41. Europe Mesalazine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Mesalazine Sales Market Share by Country in 2019
Figure 43. Europe Mesalazine Revenue Market Share by Country in 2019
Figure 44. Germany Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 45. Germany Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 47. France Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 49. U.K. Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 51. Italy Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 53. Russia Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Mesalazine Market Share by Type in 2019
Figure 55. Europe Mesalazine Market Share by Application in 2019
Figure 56. Asia Pacific Mesalazine Sales Growth Rate 2015-2020 (Ton)
Figure 57. Asia Pacific Mesalazine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Mesalazine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Mesalazine Revenue Market Share by Region in 2019
Figure 60. China Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 61. China Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 63. Japan Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 65. South Korea Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 67. India Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 69. Australia Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 71. Taiwan Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 73. Indonesia Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 75. Thailand Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 77. Malaysia Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 79. Philippines Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 81. Vietnam Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Mesalazine Market Share by Type in 2019
Figure 83. Asia Pacific Mesalazine Market Share by Application in 2019
Figure 84. Latin America Mesalazine Sales Growth Rate 2015-2020 (Ton)
Figure 85. Latin America Mesalazine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Mesalazine Sales Market Share by Country in 2019
Figure 87. Latin America Mesalazine Revenue Market Share by Country in 2019
Figure 88. Mexico Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 89. Mexico Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 91. Brazil Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 93. Argentina Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Mesalazine Market Share by Type in 2019
Figure 95. Latin America Mesalazine Market Share by Application in 2019
Figure 96. Middle East and Africa Mesalazine Sales Growth Rate 2015-2020 (Ton)
Figure 97. Middle East and Africa Mesalazine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Mesalazine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Mesalazine Revenue Market Share by Country in 2019
Figure 100. Turkey Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 101. Turkey Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 103. Saudi Arabia Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE Mesalazine Sales Growth Rate (2015-2020) (Ton)
Figure 105. UAE Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Mesalazine Market Share by Type in 2019
Figure 107. Middle East and Africa Mesalazine Market Share by Application in 2019
Figure 108. Syntese A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Divis Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Cambrex Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Ipca Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. PharmaZell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Lasa Loboratory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Erregierre SpA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Corden Pharma Bergamo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. CTX Lifescience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Ishita Active Pharma Ingredients Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. YC Biotech (Jiangsu) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Xinxiang Tianfeng Fine Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. North America Mesalazine Sales Growth Rate Forecast (2021-2026) (Ton)
Figure 121. North America Mesalazine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Europe Mesalazine Sales Growth Rate Forecast (2021-2026) (Ton)
Figure 123. Europe Mesalazine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Asia Pacific Mesalazine Sales Growth Rate Forecast (2021-2026) (Ton)
Figure 125. Asia Pacific Mesalazine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Latin America Mesalazine Sales Growth Rate Forecast (2021-2026) (Ton)
Figure 127. Latin America Mesalazine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Middle East and Africa Mesalazine Sales Growth Rate Forecast (2021-2026) (Ton)
Figure 129. Middle East and Africa Mesalazine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Porter's Five Forces Analysis
Figure 131. Channels of Distribution
Figure 132. Distributors Profiles
Figure 133. Bottom-up and Top-down Approaches for This Report
Figure 134. Data Triangulation
Figure 135. Key Executives Interviewed
  • Global Methylprednisolone Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......
  • Global Ibuprofen Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
  • Global Mesalazine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
  • Global Drugs For Sinusitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
  • Global Celecoxib Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Ibuprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Ketoprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
  • Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs